Neptune Technologies & Bioressources Inc. Increases Revenues 115% For Third Quarter

MONTREAL, April 6, 2005 /CNW Telbec/ - Neptune Technologies & Bioressources Inc. today announced its results for the third quarter ended February 28th, 2005. The company reported revenues for the quarter of $1,292,460 compared to $601,576 for the third quarter of 2004. All amounts are in Canadian dollars unless indicated otherwise.

Financial Highlights:

• Third Quarter ended February 28th, 2005.
• The operating revenues for the third quarter increased by 115% to $1,292,460 in 2005 compared to $601,576 in 2004.
• The EBITDA for the third quarter was $117,000 compared to a negative EBITDA of $240,000 in 2004.
• Nine months ended February 28th, 2005.
• The operating revenues increased by 64% to $3,606,291 in 2005 compared to $2,201,198 in 2004.
• The EBITDA is $387,000 in 2005 compared to a negative EBITDA of $862,000 in 2004.
• Third consecutive quarter that the EBITDA is positive.

"We are extremely pleased with our third quarter's results, a tremendous team effort that is being finally rewarded", commented André Godin, C.A., Vice President, Administration and Finance for Neptune Technologies & Bioressources Inc. "The turn around of our EBITDA's results for the nine months ended February 28th, 2005, is very impressive. This demonstrates management's control of our business, the market's recognition of our sales strategy and our product's superior benefits, added André Godin".

Neptune Technologies & Bioressources Inc. develops and exploits marine biomasses with its patented extraction process (Neptune OceanExtract™) utilizing marine biomasses, such as krill, and due to its technologies, Neptune Technologies & Bioressources Inc., is strategically well positioned in the $182 billion global nutrition market (Nutrition Business Journal, Oct/Nov 2004) based on the health and wellness concepts, markets in which natural biomass extraction is now playing an important role in developing nutrigenomics, the next wave in nutritional research.